Literature DB >> 12631265

Essential roles of lipoyl domains in the activated function and control of pyruvate dehydrogenase kinases and phosphatase isoform 1.

Thomas E Roche1, Yasuaki Hiromasa, Ali Turkan, Xiaoming Gong, Tao Peng, Xiaohua Yan, Shane A Kasten, Haiying Bao, Jianchun Dong.   

Abstract

Four pyruvate dehydrogenase kinase and two pyruvate dehydrogenase phosphatase isoforms function in adjusting the activation state of the pyruvate dehydrogenase complex (PDC) through determining the fraction of active (nonphosphorylated) pyruvate dehydrogenase component. Necessary adaptations of PDC activity with varying metabolic requirements in different tissues and cell types are met by the selective expression and pronounced variation in the inherent functional properties and effector sensitivities of these regulatory enzymes. This review emphasizes how the foremost changes in the kinase and phosphatase activities issue from the dynamic, effector-modified interactions of these regulatory enzymes with the flexibly held outer domains of the core-forming dihydrolipoyl acetyl transferase component.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12631265     DOI: 10.1046/j.1432-1033.2003.03468.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  24 in total

1.  Comparative homology modeling of pyruvate dehydrogenase kinase isozymes from Xenopus tropicalis reveals structural basis for their subfunctionalization.

Authors:  Alexander A Tokmakov
Journal:  J Mol Model       Date:  2011-11-09       Impact factor: 1.810

2.  Structural insight into interactions between dihydrolipoamide dehydrogenase (E3) and E3 binding protein of human pyruvate dehydrogenase complex.

Authors:  Chad A Brautigam; R Max Wynn; Jacinta L Chuang; Mischa Machius; Diana R Tomchick; David T Chuang
Journal:  Structure       Date:  2006-01-26       Impact factor: 5.006

3.  Transgenic mice aberrantly expressing pyruvate dehydrogenase complex E2 component on biliary epithelial cells do not show primary biliary cirrhosis.

Authors:  K Inamura; H Tsuji; Y Nakamoto; M Suzuki; S Kaneko
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

4.  Crystal structure of an asymmetric complex of pyruvate dehydrogenase kinase 3 with lipoyl domain 2 and its biological implications.

Authors:  Yancho Devedjiev; C Nicklaus Steussy; Dmitry G Vassylyev
Journal:  J Mol Biol       Date:  2007-05-10       Impact factor: 5.469

Review 5.  Spatial Organization of Metabolic Enzyme Complexes in Cells.

Authors:  Danielle L Schmitt; Songon An
Journal:  Biochemistry       Date:  2017-06-16       Impact factor: 3.162

Review 6.  The pyruvate dehydrogenase complexes: structure-based function and regulation.

Authors:  Mulchand S Patel; Natalia S Nemeria; William Furey; Frank Jordan
Journal:  J Biol Chem       Date:  2014-05-05       Impact factor: 5.157

7.  Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo.

Authors:  Zuzana Zachar; James Marecek; Claudia Maturo; Sunita Gupta; Shawn D Stuart; Katy Howell; Alexandra Schauble; Joanna Lem; Arin Piramzadian; Sameer Karnik; King Lee; Robert Rodriguez; Robert Shorr; Paul M Bingham
Journal:  J Mol Med (Berl)       Date:  2011-07-19       Impact factor: 4.599

8.  Crystal structure of pyruvate dehydrogenase kinase 3 bound to lipoyl domain 2 of human pyruvate dehydrogenase complex.

Authors:  Masato Kato; Jacinta L Chuang; Shih-Chia Tso; R Max Wynn; David T Chuang
Journal:  EMBO J       Date:  2005-04-28       Impact factor: 11.598

9.  Pivotal role of the C-terminal DW-motif in mediating inhibition of pyruvate dehydrogenase kinase 2 by dichloroacetate.

Authors:  Jun Li; Masato Kato; David T Chuang
Journal:  J Biol Chem       Date:  2009-10-15       Impact factor: 5.157

10.  Structural basis for inactivation of the human pyruvate dehydrogenase complex by phosphorylation: role of disordered phosphorylation loops.

Authors:  Masato Kato; R Max Wynn; Jacinta L Chuang; Shih-Chia Tso; Mischa Machius; Jun Li; David T Chuang
Journal:  Structure       Date:  2008-12-10       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.